Abstract
Radiopharmaceutical chemistry has addressed the issue of biomolecular chemistry, and radiopharmaceuticals are unique in their ability to monitor receptor binding sites and enzymes. The future of diagnostic and therapeutic nuclear medicine, to study the in vivo metabolism, is focused on the use of radiolabeled protein fragments, peptide structures and DNA chains. These radiolabeled molecules represent a substantial change in the paradigms of the pharmaceutical development by employing, as a source of pharmaceuticals, capabilities of our own body, instead of considering it as a simple test-tube where strange molecules interact. Research on biomolecules complexed to radioactive metals, like Tc- 99m, Re-188, Lu-177 and Y-90, that do not alter the molecular specificity, is a topic of world interest in radiopharmaceutical investigations. Some perspectives and achievements on the preparation and analysis of main diagnostic and therapeutic radiopharmaceuticals of the third generation are presented.
Keywords: Radiolabeled biomolecules, Radiopharmaceuticals, Technetium-99m, Rhenium-188, Lutetium-177, Yttrium-90
Current Pharmaceutical Analysis
Title: Third Generation Radiopharmaceuticals for Imaging and Targeted Therapy
Volume: 2 Issue: 4
Author(s): Guillermina Ferro-Flores, Consuelo Arteaga de Murphy and Laura Melendez-Alafort
Affiliation:
Keywords: Radiolabeled biomolecules, Radiopharmaceuticals, Technetium-99m, Rhenium-188, Lutetium-177, Yttrium-90
Abstract: Radiopharmaceutical chemistry has addressed the issue of biomolecular chemistry, and radiopharmaceuticals are unique in their ability to monitor receptor binding sites and enzymes. The future of diagnostic and therapeutic nuclear medicine, to study the in vivo metabolism, is focused on the use of radiolabeled protein fragments, peptide structures and DNA chains. These radiolabeled molecules represent a substantial change in the paradigms of the pharmaceutical development by employing, as a source of pharmaceuticals, capabilities of our own body, instead of considering it as a simple test-tube where strange molecules interact. Research on biomolecules complexed to radioactive metals, like Tc- 99m, Re-188, Lu-177 and Y-90, that do not alter the molecular specificity, is a topic of world interest in radiopharmaceutical investigations. Some perspectives and achievements on the preparation and analysis of main diagnostic and therapeutic radiopharmaceuticals of the third generation are presented.
Export Options
About this article
Cite this article as:
Ferro-Flores Guillermina, Arteaga de Murphy Consuelo and Melendez-Alafort Laura, Third Generation Radiopharmaceuticals for Imaging and Targeted Therapy, Current Pharmaceutical Analysis 2006; 2 (4) . https://dx.doi.org/10.2174/157341206778699555
DOI https://dx.doi.org/10.2174/157341206778699555 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Possible Role of Vascular Risk Factors in Alzheimer's Disease and Vascular Dementia
Current Pharmaceutical Design Mood Disorders in Elderly Population: Neurostimulative Treatment Possibilities
Recent Patents on CNS Drug Discovery (Discontinued) Emerging Treatments in Acute Lymphoblastic Leukemia
Current Cancer Drug Targets Formulation and <i>In vitro</i> Evaluation of Nystatin-loaded Albumin Microparticles for the Treatment of Leishmaniosis
Micro and Nanosystems Milestones in Antihypertensive Drug Treatment
Current Pharmaceutical Design A Paradigm Shift in the Development of Anti-Candida Drugs
Current Topics in Medicinal Chemistry Management of Food-Induced Anaphylaxis: Unsolved Challenges
Current Clinical Pharmacology Canagliflozin : A New Hope in the Antidiabetic Armamentarium
Recent Patents on Cardiovascular Drug Discovery Single-dose Pharmacokinetics and Tolerability of Oral Delta-9- Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis
Drug Metabolism Letters Atypical Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children: A Systematic Review
Current Pediatric Reviews Retraction Notice: Prevention of Emetic Episodes During Cesarean Delivery Performed Under Regional Anesthesia in Parturients
Current Drug Safety Meet Our Editorial Board Member
Current Pharmaceutical Biotechnology Himalayan Plants as a Source of Anti-Cancer Agents: A Review
The Natural Products Journal Data-driven Approach to Detect and Predict Adverse Drug Reactions
Current Pharmaceutical Design The Use of Carvedilol in Pediatric Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets Indications for Non-Invasive Ventilation in Respiratory Failure
Reviews on Recent Clinical Trials Addiction Liability of Pharmacotherapeutic Interventions in Obesity
Current Pharmaceutical Design Incidence and Prevention of Thromboembolic Events in One Stage Bilateral Total Hip Arthroplasty: A Systematic Review
Current Vascular Pharmacology Mexiletine Metabolites: A Review
Current Medicinal Chemistry Bioactive Cyclohexenones: A Mini Review
Current Bioactive Compounds